表达O型口蹄疫病毒VP1基因的重组牛疱疹病毒1型的构建及其在兔体内的免疫原性研究
|
摘要
牛传染性鼻气管炎(Infectious bovine rhinotracheitis,IBR)是由牛疱疹病毒1型(Bovine hepervirus-1,BHV-1)引起的以牛呼吸道病为主要临床症状的疾病,是造成养牛业损失的一种重要传染病。BHV-1为α疱疹病毒,基因组为135kb左右的双链DNA,像其他疱疹病毒一样,BHV-1基因组中有许多病毒复制非必需基因,可允许插入外源DNA,且BHV-1具有感染宿主范围小,弱毒株致弱背景明确的优点,是最有望成为构建多价牛传染病疫苗的理想载体,现已有很多外源病毒DNA成功地插入到了BHV-1基因组中。
口蹄疫(Foot and mouth disease,FMD)是由口蹄疫病毒(Foot and mouth disease virus,FMDV)引起偶蹄动物的一种高度接触性、传染性疾病,FMD能够形成全球大规模流行,造成巨大经济损失。FMDV属于小RNA病毒科,基因组为单股正链RNA。研究证实结构蛋白VP1具有与细胞受体结合的主要功能,是病毒感染细胞的关键,且VP1蛋白可在体外实验及自然宿主中诱导产生中和抗体,是研究各种FMD基因工程疫苗的首要候选蛋白。
本研究旨在构建表达FMDV(O/China/99)VP1基因的重组BHV-1,并对其部分生物学特性以及在动物体内的免疫原性进行研究,为研制口蹄疫及其他重要牛传染病的BHV-1病毒载体疫苗奠定基础。
为了构建表达O型FMDV(O/China /99)VP1基因的重组BHV-1,利用人工合成的基因质粒与构建BHV-1 gE基因缺失转移载体时所用的质粒,构建了含VP1表达盒的gE基因缺失转移载体,该载体含有巨细胞病毒(cytomegalovirus,CMV)早期启动子控制下的VP1基因、以及用于同源重组的BHV-1gE基因上游与下游同源重组序列。采用磷酸钙介导转染法将该转移载体与自行构建的呈gE基因缺失、并引入大肠杆菌β-半乳糖苷酶基因(β-Galactosidase gene,LacZ)的重组病毒BHV-1/gE-/LacZ+基因组DNA共转染牛鼻甲细胞,采用反向病毒蚀斑筛选法,获得了表达VP1基因的重组病毒BHV-1/gE-/VP1,PCR检测结果表明VP1基因已经插入到了重组病毒BHV-1/gE-的基因组中,间接免疫荧光试验和Western blot证实了BHV-1/gE-/VP1中的VP1基因在感染的细胞中获得了表达。
为了鉴定FMDV(O/China/99)VP1基因在BHV-1/gE-/VP1感染细胞中的表达,以原核表达系统表达了FMDV(O/China/99)VP1基因并制备了其多克隆抗体作为基础材料。首先采用PCR方法从质粒pUC57-VP1中扩增FMDV VP1基因,并将其克隆至原核表达载体pET-30a(+)中,获得重组质粒pET30a-VP1。重组质粒鉴定正确后,转化至大肠杆菌BL21感受态细胞,经IPTG诱导后,SDS-PAGE结果显示重组蛋白的分子量约为38ku,以包涵体的形式存在。Western blot与间接ELISA结果显示重组蛋白能够与FMD阳性血清反应。将初步纯化的重组蛋白免疫BALB/c鼠制备多克隆抗体,作为鉴定VP1基因在重组病毒感染的细胞中获得表达的基础材料。
为了比较BHV-1/gE-/VP1与亲本病毒(BHV-1/gE-/LacZ+)之间的增殖能力、BHV-1/gE-/VP1的遗传稳定性以及在动物体内的免疫原性,测定了BHV-1/gE-/VP1和BHV-1/gE-/LacZ+在MDBK细胞上的半数组织培养感染量(50% tissue culture infective dose,TCID50);并将BHV-1/gE-/VP1连续在MDBK细胞上传15代,取5、10、15代病毒,提取病毒基因组DNA后扩增VP1基因;以及将1ml 1×107.0 TCID50的BHV-1/gE-/VP1和1ml 1×107.0 TCID50的BHV-1/gE-/LacZ+分别皮下免疫4只新西兰白兔后,每周采血,首免两周以同样剂量加强免疫,分别采用病毒中和试验和间接ELISA法检测免疫动物血清中的IBRV和FMDV VP1的抗体。结果表明BHV-1/gE-/VP1和BHV-1/gE-/LacZ+的TCID50分别为107.9/ml和107.3/ml;以5、10、15代病毒基因组DNA为模板均能扩增出VP1基因;中和试验和ELISA能够分别检测到BHV-1/gE-/VP1免疫动物血清中的IBRV和FMDV VP1的抗体。
本研究构建了表达FMDV VP1基因的重组病毒BHV-1/gE-/VP1,且VP1基因能够在感染BHV-1/gE-/VP1的细胞中获得表达;与BHV-1/gE-/LacZ+相比,BHV-1/gE-/VP1的增殖能力无差异,VP1基因也能在BHV-1/gE-/VP1的传代过程中稳定存在;动物试验表明BHV-1/gE-/VP1能够诱导兔体产生抗IBRV和FMDV VP1蛋白的抗体。该研究为研制口蹄疫及其他重要牛传染病的BHV-1病毒载体疫苗奠定了基础。
Infectious bovine rhinotracheitis (IBR) is a widespread viral disease of cattle that causes serious economic losses in the cattle industry worldwide. The causative virus is bovine herpesvirus type 1(BHV-1), commonly known as infectious bovine rhinotracheitis virus, a member of the Herpesviridae family, alpha herpesvirinae subfamily. BHV-1 consists of double-stranded linear DNA with an approximate size of 135 kb, and foreign genes can be stably inserted into the genome of BHV-1, which makes the BHV-1 a promising candidate for the development of a live vaccine vector for economically important bovine diseases. Several recombinants expressing immunogenic foreign proteins have been reported as vaccines for other infectious diseases.
Foot-and-mouth disease virus (FMDV) is the causative agent of a highly contagious and economically important disease affecting cloven-hoofed animals. FMDV consists of a single-stranded, positive-sense RNA genome of approximately 8,500 bases surrounded by four structural proteins, VP1, VP2, VP3 and VP4. It has been demonstrated that VP1 could induce neutralizing antibodies in the experimental and natural hosts and also involved in the interaction between virus and cell surface receptor. So the VP1 is a target protein for develop new vaccine for FMD. This research was aimed at constructing a recombinant BHV-1 expressing VP1 gene of FMDV as a candidate vaccine strain to develop a novel bivalent vaccine against FMD and IBR.
In order to construct the recombinant BHV-1 which expressing FMDV VP1 gene, we constructed a BHV-1 gE gene transfer vector by inserting the synthetic VP1 gene of FMDV (O/China/99) under the immediate-early promoter of cytomegalovirus. The mixtures of parental virus (BHV-1/gE-/LacZ+) DNA and transfer vector were cotransfected into bovine turbinate cells using calcium phosphate-mediated transfection. Then the propagated viruses were harvested. The recombinant BHV-1 (designated BHV-1/gE-/VP1) was obtained by selection for white virus plaques. PCR results showed that VP1 gene was successfully inserted into the genome of BHV-1/gE-. The expression of VP1 in infected cells was proved by indirect immunofluorescence assay and Western blotting.
In order to express foot and mouth disease viru(sFMDV)(O /China /99)VP1 gene and prepare the VP1 protein polyclonal antibody for providing a basic materials for identification of VP1 expression in cells infected BHV-1/gE-/VP1, the VP1 gene was amplified by PCR from the plasmid pUC57-VP1 and cloned into the prokaryotic expression vector pET-30a(+). the recombinant plasmid pET30a-VP1 was transformed into E.coli BL21 after confirmation and then induced with IPTG, SDS-PAGE result showed that a protein approximately 38ku was expressed in inclusion body. Western blot and indirect ELISA results showed that recombinant protein can react with FMD positive serum. The BALB/c mice were immunized with pirmarily purified recombinant protein to prepare polyclonal antibody againist the VP1.
To compare the multiplication capacity between BHV-1/gE-/VP1 and BHV-1/gE-/LacZ+, the 50% tissue culture infective dose (TCID50) was calculated, they were 107.9/ml and 107.3/ml respectively. To analyze the genetic character of BHV-1/gE-/VP1, 5,10,15 passages of BHV-1/gE-/VP1 DNA were taken as templet for PCR, the result showed that VP1 gene can be amplificated. Eight New Zealand white rabbits were randomly divided into two groups, the rabbits were inoculated subcutaneously with 1 ml 1×10~(7.0) TCID_(50) BHV-1/gE-/VP1 and 1 ml 1×10~(7.0) TCID_(50) vector virus respectively. The second inoculation was given with the same dose at two weeks post-inoculation and the blood samples were obtained once a week, and sera were collected to determine the presence of antibodies against IBRV and VP1 protein. The immunogenicity was confirmed in a rabbit model by virus neutralization test and ELISA.
We successfully constructed BHV-1/gE-/VP1 which expressing foot and mouth disease virus VP1 gene. BHV-1/gE-/VP1 had similar multiplication capacity compared with BHV-1/gE-/LacZ~+ and had stable genetic character. And the immunogenicity was confirmed in a rabbit model. This research provided a technical platform and basis for applying BHV-1 as vector for development recombinant vaccine of expressing FMDV VP1 gene and other foreign genes.
口蹄疫(Foot and mouth disease,FMD)是由口蹄疫病毒(Foot and mouth disease virus,FMDV)引起偶蹄动物的一种高度接触性、传染性疾病,FMD能够形成全球大规模流行,造成巨大经济损失。FMDV属于小RNA病毒科,基因组为单股正链RNA。研究证实结构蛋白VP1具有与细胞受体结合的主要功能,是病毒感染细胞的关键,且VP1蛋白可在体外实验及自然宿主中诱导产生中和抗体,是研究各种FMD基因工程疫苗的首要候选蛋白。
本研究旨在构建表达FMDV(O/China/99)VP1基因的重组BHV-1,并对其部分生物学特性以及在动物体内的免疫原性进行研究,为研制口蹄疫及其他重要牛传染病的BHV-1病毒载体疫苗奠定基础。
为了构建表达O型FMDV(O/China /99)VP1基因的重组BHV-1,利用人工合成的基因质粒与构建BHV-1 gE基因缺失转移载体时所用的质粒,构建了含VP1表达盒的gE基因缺失转移载体,该载体含有巨细胞病毒(cytomegalovirus,CMV)早期启动子控制下的VP1基因、以及用于同源重组的BHV-1gE基因上游与下游同源重组序列。采用磷酸钙介导转染法将该转移载体与自行构建的呈gE基因缺失、并引入大肠杆菌β-半乳糖苷酶基因(β-Galactosidase gene,LacZ)的重组病毒BHV-1/gE-/LacZ+基因组DNA共转染牛鼻甲细胞,采用反向病毒蚀斑筛选法,获得了表达VP1基因的重组病毒BHV-1/gE-/VP1,PCR检测结果表明VP1基因已经插入到了重组病毒BHV-1/gE-的基因组中,间接免疫荧光试验和Western blot证实了BHV-1/gE-/VP1中的VP1基因在感染的细胞中获得了表达。
为了鉴定FMDV(O/China/99)VP1基因在BHV-1/gE-/VP1感染细胞中的表达,以原核表达系统表达了FMDV(O/China/99)VP1基因并制备了其多克隆抗体作为基础材料。首先采用PCR方法从质粒pUC57-VP1中扩增FMDV VP1基因,并将其克隆至原核表达载体pET-30a(+)中,获得重组质粒pET30a-VP1。重组质粒鉴定正确后,转化至大肠杆菌BL21感受态细胞,经IPTG诱导后,SDS-PAGE结果显示重组蛋白的分子量约为38ku,以包涵体的形式存在。Western blot与间接ELISA结果显示重组蛋白能够与FMD阳性血清反应。将初步纯化的重组蛋白免疫BALB/c鼠制备多克隆抗体,作为鉴定VP1基因在重组病毒感染的细胞中获得表达的基础材料。
为了比较BHV-1/gE-/VP1与亲本病毒(BHV-1/gE-/LacZ+)之间的增殖能力、BHV-1/gE-/VP1的遗传稳定性以及在动物体内的免疫原性,测定了BHV-1/gE-/VP1和BHV-1/gE-/LacZ+在MDBK细胞上的半数组织培养感染量(50% tissue culture infective dose,TCID50);并将BHV-1/gE-/VP1连续在MDBK细胞上传15代,取5、10、15代病毒,提取病毒基因组DNA后扩增VP1基因;以及将1ml 1×107.0 TCID50的BHV-1/gE-/VP1和1ml 1×107.0 TCID50的BHV-1/gE-/LacZ+分别皮下免疫4只新西兰白兔后,每周采血,首免两周以同样剂量加强免疫,分别采用病毒中和试验和间接ELISA法检测免疫动物血清中的IBRV和FMDV VP1的抗体。结果表明BHV-1/gE-/VP1和BHV-1/gE-/LacZ+的TCID50分别为107.9/ml和107.3/ml;以5、10、15代病毒基因组DNA为模板均能扩增出VP1基因;中和试验和ELISA能够分别检测到BHV-1/gE-/VP1免疫动物血清中的IBRV和FMDV VP1的抗体。
本研究构建了表达FMDV VP1基因的重组病毒BHV-1/gE-/VP1,且VP1基因能够在感染BHV-1/gE-/VP1的细胞中获得表达;与BHV-1/gE-/LacZ+相比,BHV-1/gE-/VP1的增殖能力无差异,VP1基因也能在BHV-1/gE-/VP1的传代过程中稳定存在;动物试验表明BHV-1/gE-/VP1能够诱导兔体产生抗IBRV和FMDV VP1蛋白的抗体。该研究为研制口蹄疫及其他重要牛传染病的BHV-1病毒载体疫苗奠定了基础。
Infectious bovine rhinotracheitis (IBR) is a widespread viral disease of cattle that causes serious economic losses in the cattle industry worldwide. The causative virus is bovine herpesvirus type 1(BHV-1), commonly known as infectious bovine rhinotracheitis virus, a member of the Herpesviridae family, alpha herpesvirinae subfamily. BHV-1 consists of double-stranded linear DNA with an approximate size of 135 kb, and foreign genes can be stably inserted into the genome of BHV-1, which makes the BHV-1 a promising candidate for the development of a live vaccine vector for economically important bovine diseases. Several recombinants expressing immunogenic foreign proteins have been reported as vaccines for other infectious diseases.
Foot-and-mouth disease virus (FMDV) is the causative agent of a highly contagious and economically important disease affecting cloven-hoofed animals. FMDV consists of a single-stranded, positive-sense RNA genome of approximately 8,500 bases surrounded by four structural proteins, VP1, VP2, VP3 and VP4. It has been demonstrated that VP1 could induce neutralizing antibodies in the experimental and natural hosts and also involved in the interaction between virus and cell surface receptor. So the VP1 is a target protein for develop new vaccine for FMD. This research was aimed at constructing a recombinant BHV-1 expressing VP1 gene of FMDV as a candidate vaccine strain to develop a novel bivalent vaccine against FMD and IBR.
In order to construct the recombinant BHV-1 which expressing FMDV VP1 gene, we constructed a BHV-1 gE gene transfer vector by inserting the synthetic VP1 gene of FMDV (O/China/99) under the immediate-early promoter of cytomegalovirus. The mixtures of parental virus (BHV-1/gE-/LacZ+) DNA and transfer vector were cotransfected into bovine turbinate cells using calcium phosphate-mediated transfection. Then the propagated viruses were harvested. The recombinant BHV-1 (designated BHV-1/gE-/VP1) was obtained by selection for white virus plaques. PCR results showed that VP1 gene was successfully inserted into the genome of BHV-1/gE-. The expression of VP1 in infected cells was proved by indirect immunofluorescence assay and Western blotting.
In order to express foot and mouth disease viru(sFMDV)(O /China /99)VP1 gene and prepare the VP1 protein polyclonal antibody for providing a basic materials for identification of VP1 expression in cells infected BHV-1/gE-/VP1, the VP1 gene was amplified by PCR from the plasmid pUC57-VP1 and cloned into the prokaryotic expression vector pET-30a(+). the recombinant plasmid pET30a-VP1 was transformed into E.coli BL21 after confirmation and then induced with IPTG, SDS-PAGE result showed that a protein approximately 38ku was expressed in inclusion body. Western blot and indirect ELISA results showed that recombinant protein can react with FMD positive serum. The BALB/c mice were immunized with pirmarily purified recombinant protein to prepare polyclonal antibody againist the VP1.
To compare the multiplication capacity between BHV-1/gE-/VP1 and BHV-1/gE-/LacZ+, the 50% tissue culture infective dose (TCID50) was calculated, they were 107.9/ml and 107.3/ml respectively. To analyze the genetic character of BHV-1/gE-/VP1, 5,10,15 passages of BHV-1/gE-/VP1 DNA were taken as templet for PCR, the result showed that VP1 gene can be amplificated. Eight New Zealand white rabbits were randomly divided into two groups, the rabbits were inoculated subcutaneously with 1 ml 1×10~(7.0) TCID_(50) BHV-1/gE-/VP1 and 1 ml 1×10~(7.0) TCID_(50) vector virus respectively. The second inoculation was given with the same dose at two weeks post-inoculation and the blood samples were obtained once a week, and sera were collected to determine the presence of antibodies against IBRV and VP1 protein. The immunogenicity was confirmed in a rabbit model by virus neutralization test and ELISA.
We successfully constructed BHV-1/gE-/VP1 which expressing foot and mouth disease virus VP1 gene. BHV-1/gE-/VP1 had similar multiplication capacity compared with BHV-1/gE-/LacZ~+ and had stable genetic character. And the immunogenicity was confirmed in a rabbit model. This research provided a technical platform and basis for applying BHV-1 as vector for development recombinant vaccine of expressing FMDV VP1 gene and other foreign genes.
引文
1.陈昌海,程雷,徐正军,等. AsiaⅠ型口蹄疫病毒江苏分离株VP1基因的克隆与高效表达[J].西北农林科技大学学报(自然科学版),2008,36(7):9-13
2.陈关平. O型口蹄疫与伪狂犬病二价基因工程疫苗的研究.博士学位论文.武汉:华中农业大学,2008.
3.陈焕春,方六荣,何启盖,等.猪伪狂犬病病毒鄂A株的分离鉴定[J].畜牧兽医学报, 1998 2:161-166.
4.陈焕春,周复春,方六荣,等.伪狂犬病病毒鄂A株TK-/gG-/LacZ+突变株的构建[J].病毒学报,2001,17(1):69–74.
5.邓沛霖,贺荣莲,黄峻,等.传染性牛鼻气管炎隐性感染牛的病毒分离[J].中国兽医杂志, 1986, 11: 4-6.
6.邓沛霖,贺荣莲,黄峻,等.广西牛传染性鼻气管炎的血清学调查[J].中国动物检疫, 1988, 1: 11-13.
7.董志强,张志,李晓成,等.口蹄疫病毒VP1基因的克隆及结构蛋白VP1的原核表达[J].中国动物检疫,2007,24(2):23-25
8.段舒怡,姜平,李玉峰,等. O型口蹄疫病毒VP1蛋白单克隆抗体的制备与生物学特性鉴定[J].中国人兽共患病学报,2007,23 (3):240-243
9.费恩阁,李德昌,丁壮. 2004.动物疫病学[M].北京:中国农业出版社. 336-341.
10.谷长维,金宁一,霍晓伟,等.共表达口蹄疫病毒O型P1-2A-IL-18基因和Asia I型P1-2A-3C基因重组鸡痘病毒的构建[J].中国生物制品学杂志,2007,8:658-661
11.郭巍,朱远茂,薛飞等.牛疱疹病毒1型作为活病毒载体的研究进展.中国生物工程杂志, 2005:32-35
13.海岗.表达FMDV vp1基因和山羊γ-干扰素基因的重组山羊痘病毒的构建及其生物学特性研究.博士学位论文.北京:中国农业科学院研究生院,2008.
14.金宁一,张洪勇,尹革芬,等.共表达口蹄疫病毒衣壳蛋白前体P1-2A基因和蛋白酶3C基因重组鸡痘病毒的构建及其免疫原性[J].科学通报,2004,6:576-579
15.孔繁德. 2006.进口奶牛牛传染性鼻气管炎病毒的分离与鉴定[J].中国动物检疫. 23(4): 29-30.
16.李娇,薛飞,朱远茂,等.牛病毒性腹泻病毒E2蛋白的截短表达与鉴定[J].中国预防兽医学报,2008,30(3):200-205
17.李润成,余兴龙,白霞,等. O型口蹄疫病毒代表性抗原VP1基因的人工合成与表达及其免疫原性检测[J].湖南农业大学学报(自然科学版),2008,34(3):334-337
18.刘正飞,陈焕春,周复春,等.伪狂犬病病毒Bartha株TK-/LacZ+突变株的构建及其生物学特性研究[J].畜牧兽医学报,2002,(3):304-307
19.卢曾军,曹轶梅,包惠芳,等.同源重组法制备口蹄疫病毒多基因重组腺病毒[J].中国病毒学,2004(2):30-33
20.吕建亮.口蹄疫病毒泛亚型0/CHINA/99株(全长、缺失和置换)cDNA分子克隆构建和感染性鉴定.硕士学位论文.中国农业科学院研究生院,2008.
21.马鸣潇. FMDV分子背景分析、病毒拯救及多价基因工程疫苗研究.博士学位论文.长春:吉林大学,2007.
22.冉波,邵明玉,张培,等. O型口蹄疫病毒VP1表位重组蛋白疫苗的构建、表达和纯化[J].免疫学杂志,2006,22(3)265-268.
23.王芳.表达FMDV vp1基因的重组山羊痘病毒的构建及其生物学特性研究.博士学位论文.北京:中国农业科学院研究生院,2008.
24.王延涛,李国军,周玉龙,等. 2007.牛传染性鼻气管炎病毒分离鉴定[J].中国兽医杂志. 43(5):30-31.
25.王则兴,李崇华,代瑞良,等.牦牛IBR病毒的分离与鉴定[J].中国兽医科技, 1986, 8: 5-6.
26.薛飞,相文华,沈荣显.山羊试验感染绵羊进行性肺炎病毒的抗体应答反应[J].中国兽医学报,1998,(18):126-128
27.颜邦芬,陈锃,张书环,等.牛传染性鼻气管炎病毒gG蛋白的表达及gG-ELISA的建立[J].生物工程学报,2007,5:806-811.
28.颜邦芬.牛传染性鼻气管炎病毒抗体间接ELISA的建立及其在流行病学研究中的应用.硕士学位论文.武汉:华中农业大学,2007.
29.杨琴,顾江,毛旭虎,等.肠出血性大肠杆菌O157∶H7 TccP基因克隆、表达及其抗原性鉴定[J].中国人兽共患病学报,2007,23 (4):319-322
30.张强.表达口蹄疫病毒P1-2A3C基因的山羊痘病毒弱毒株构建及其复制非必需区筛选博士学位论文.北京:中国农业科学院研究生院,2007.
31.张显升,刘在新,赵启组等.口蹄疫病毒China/99基因组RNA序列测定及比较分析[J].中国科学(C辑),2003,33(5):461-467
32.张永光,吕建亮,王永录,等.口蹄疫O/China/99毒株在不同宿主系传代的3A和VP1基因变异研究[J].病毒学报,2004,20(4)338-346
33.中国农业科学院哈尔滨兽医研究所.动物传染病学,2008,北京:中国农业出版社.
34.周泰冲,叶章名,黎少权,等.从新西兰进口奶牛中分离牛传染性鼻气管炎病毒[J].兽医科技杂志, 1981,1:6-9.
35.朱晶晶,魏玉荣,符子华,等.口蹄疫病毒VP1基因研究进展[J].动物医学进展,2008,29(7):75-78
36.庄娟,曹祥荣,陈波录等. O型口蹄疫病毒VP1 T细胞与B细胞表位基因双拷贝串联表达产物的免疫应答[J].中国预防兽医学报,2005,27(6):494-497
37.祖立闯,朱远茂,王延辉,等.牛传染性鼻气管炎病毒重组gD蛋白间接ELISA方法的建立及应用[J].中国预防兽医学报, 2008,7:537-543.
38.祖立闯.牛传染性鼻气管炎病毒重组gD蛋白间接ELISA的建立与应用.硕士学位论文.哈尔滨:东北农业大学,2008.
39. Abril C., Engels M., Liman A., et al. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient micel[J].J. Viro, 2004,78:3644-3653.
40. Abu-El-Saad AA, Abdel-Moneim AS. Modulation of macrophage functions by sheeppox virusprovides clues to understand interaction of the virus with host immune system[J]. Virol J. 2005, 22:2-22.
41. Ackermann M., Engels M., Pro and contra IBR-eradication [J].Vet.Microbiol,2006 113:293-302 .
42. Ackermann M., Engels M., Pro and contra IBR-eradication[J].Vet Microbiol,2006,113:293–302.
43. AFFA. Discussion paper on bovine herpesvirus 1. Agriculture, Fisheries and Forestry - Australia, Canberra, 2000.
44. Afonso CL, Tulman ER, Lu Z, Zsak L, et.al The genome of swinepox virus[J]. J Virol. 2002 76(2):783-90.
45. Antinone S.E., Shubeita G.T., Coller K.E., et al. The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus[J]. J. Viro, 2006, 80:5494-5498 .
46. Babiuk L.A., van Drunen Littel-van den Hurk S., Tikoo S.K., Immunology of bovine herpesvirus 1 infection[J].Vet. Microbiol,1996,53:31-42 .
47. Bello L.J., Whitbeck J.C., Lawrence W.C. et.al. Bovine herpesvirus 1 as a live virus vector for expression of foreign genes[J]. Virology, 1992,190:666-673.
48. Berhe G, Minet C, Le Goff C, et.al Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections [J] J Virol,2003 77(2):1571-7.
49. Berinstein A, Tami C, Taboga O, et.al Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus[J].Vaccine. 2000, 18(21):2231-8.
50. Bernard Roizman, Frank J.Jenkins et.al Genetic engineering of novel genomes of large DNA viruses[J]. Science, 1985,229:1208-1213.
51. Boelaert F., Speybroeck N., de Kruif A., et al. Risk factors for bovine herpesvirus-1 seropositivity [J].Prev. Vet. Med,2005, 69:285-295 .
52. Bradshaw B.J., Edwards S., Antibody isotype responses to experimental infection with bovine herpesvirus 1 in calves with colostrally derived antibody[J]. Vet. Microbiol,1996, 53:143-151 .
53. Brake, F., Studdert, M.J.. Molecular epidemiology and pathogenesis of ruminant herpesviruses including bovine, buffalo and caprine herpesviruses l and bovine encephalitis herpesvirus[J]. Australian Veterinary Journal, 1985, 62: 331-334.
54. Brown T.T. Jr., Ananaba G., Effect of respiratory infections caused by bovine herpesvirus-1 or parainfluenza-3 virus on bovine alveolar macrophage functions[J]. Am. J. Vet. Res,1988, 49:1447-1451.
55. Campadelli-Fiume G., Cocchi F., Menotti L., Lopez M., The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells l[J]. Rev. Med. Viro, 2000,10:305-319.
56. Campos M., Ohmann H.B., Hutchings D., R et.al Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells[J].Cell. Immunol,1989,120:259-269
57. Campos M., Rossi C.R., Cytotoxicity of bovine lymphocytes after treatment with lymphokines[J].Am. J. Vet. Res,1986, 47:1524-1528.
58. Chow T.L., Molello J.A., Owen N.V., Abortion experimentally induced in cattle by infectious bovine rhinotracheitis virus, J. Am. Vet. Med. Assoc,1964,144:1005-1007.
59. Denis M., Splitter G., Pastoret P.-P., Babiuk L.A., Infectious bovine rhinotracheitis (bovine herpesvirus 1): helper T cells, cytotoxic T cells and NK cells, CRC Press, Boca Raton, 1994.
60. Doel TR. FMD vaccines. Virus Res[J]. 2003;91:81–9
61. D'Offay J.M., Mock R.E., Fulton R.W., Isolation and characterization of encephalitic bovine herpesvirus type 1 isolates from cattle in North America[J]. Am. J. Vet. Res,1993,54:534-539.
62. Dohner K., Wolfstein A., Prank U., Echeverri C., Dujardin D., Vallee R., Sodeik B., Function of dynein and dynactin in herpes simplex virus capsid transport[J]. Mol. Biol. Cell, 2002,13:2795-2809 .
63. Donofrio G, Cavirani S, Vanderplasschen A, et al. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model [J]. Clin Vaccine Immunol,2006,11:1246-54.
64. Donofrio G, Sartori C, Franceschi V,et al. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD[J]. Vaccine,2008,48:6031-42.
65. Du Y, Jiang P, Li Y et al. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor[J].Vaccine,2007,25: 8209-8219
66. Edwards S., Newman R.H., White H., The virulence of British isolates of bovid herpesvirus 1 in relationship to viral genotype[J]. Br. Vet. J,1991,147:216-231.
67. Edwards S., White H., Nixon P., A study of the predominant genotypes of bovid herpesvirus 1 found in the UK[J]. Vet. Microbiol,1990,22:213-223 .
68. Engels M., Steck F., Wyler R., Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction endonuclease analysis[J]. Arch. Virol, 1981,67:169-174 .
69. Garabed RB, Johnson WO, Thurmond MC. Analytical Epidemiology of Genomic Variation among PanAsia Strains of Foot-and-Mouth Disease Virus[J]. Transbound Emerg Dis, 2009,56: 142-56.
70. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G., Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor[J].Science ,1998, 280:1618-1620 .
71. Gerdts V., Beyer J., Lomniczi B., Mettenleiter T.C., Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence[J]. J. Virol,2000,74:817-827 .
72. Gerdts V., Beyer J., Lomniczi B., Mettenleiter T.C., Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence, J.Virol,2000,74:817-827 .
73. Gibbs E.P., Rweyemamu M.M., Bovine herpesviruses. Part I. Bovine herpesvirus 1[J]. Vet. Bull. 1977, 47:317-343.
74. Gogev S., de Fays K., Versali M.F., et.al, Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1[J].Vaccine ,2004,22:1946-1953 .
75. Gogev S., Georgin J.P., Schynts F., et.al Bovine herpesvirus 1 glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 5[J].Vet. Res,2004,35:715-721.
76. Gogev S., Vanderheijden N., Lemaire M., et.al Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD[J]. Vaccine ,2002,20:1451-1465 .
77. Hage J.J., Schukken Y.H., Dijkstra T., Barkema H.W., van Valkengoed P.H., Wentink G.H., Milk production and reproduction during a subclinical bovine herpesvirus 1 infection on a dairy farm[J]. Prev. Vet. Med,1998,34:97-106 .
78. Hage J.J., Vellema P., Schukken Y.H., Barkema H.W., Rijsewijk F.A., van Oirschot J.T., Wentink G.H., Sheep do not have a major role in bovine herpesvirus 1 transmission[J]. Vet. Microbiol, 1997,57:41-54 .
79. Horiuchi M., Yamazaki N., Furuoka H., et.al Restriction endonuclease analysis of bovine herpesvirus type 1 isolates from calves with fatal encephalitis: comparison with vaccine virus[J].J. Vet. Med. Sci,1995, 57:577-580.
80. Ioannou X.P., Griebel P., Hecker R., et.al The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides[J]. J. Virol,2002,76:9002-9010 .
81. Kaashoek M.J., Straver P.H., Van R.E., Quak J., van Oirschot J.T., Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects[J]. Vet. Rec,1996,139:416-421.
82. Kerkhofs P., Renjifo X., Toussaint J.F., Letellier C., Vanopdenbosch E., Wellemans G., Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine[J]. Vet. Rec,2003,152:681-686.
83. King AM, Underwood BO, McCahon D, Newman JW, Brown F Biochemical identification of viruses causing the 1981 outbreaks foot and mouth disease in the UK[J]. Nature 1981;293:479–80.
84. Kit, M., Kit, S., Little, S.P., Di Marchi, R.D., Gale, C.. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine, 1991a, 9: 564-572.
85. Kit, S., Kit, M., DiMarchi, R.D., et.al Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles[J]. Archives of Virology, 1991b, 120: 1-17.
86. Kit, S., Kit, M., McConnell, S.. Intramuscular and intravaginal vaccination of pregnant cows withthymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpes virus 1) [J]. Vaccine, 1986, 4: 55-61.
87. Kit, S., Otsuka, H., Kit, M.. Blocking ELISA for distinguishing infectious bovine rhinotracheitis virus(IBRV)-infected animals from those vaccinated with a gene-deleted marker vaccine[J]. Journal of Virological Methods, 40: 45-56.
88. Kit, S., Qavi, H., Gaines, J.D., et.al Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves[J]. Archives of Virology, 1985, 86: 63-83.
89. Koppers-Lalic D., Reits E.A., Ressing M.E., et.al Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing, Proc. Natl. Acad. Sci. USA [J].2005, 102:5144-5149 .
90. Koppers-Lalic D., Rijsewijk F.A., Verschuren S.B., et.al The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1[J]. J. Gen. Virol,2001, 82:2071-2081.
91. Kuhnle, G., Heinze, A., Schmitt, J., et al. The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1[J]. Journal of Virology, 1998,72,3804-3811.
92. Kweon CH, Kang SW, Choi EJ et al. Bovine herpes virus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate[J]. J. Vet. Med. Sci., 1999, 61(4): 395-401
93. Lehmann D., Sodoyer R., Leterme S., et.al Improvement of serological discrimination between herpesvirus-infected animals and animals vaccinated with marker vaccines[J]. Vet. Microbiol, 2002,86:59-68 .
94. Leite F., Atapattu D., Kuckleburg C., Schultz R., Czuprynski C.J., Incubation of bovine PMNs with conditioned medium from BHV-1 infected peripheral blood mononuclear cells increases their susceptibility to Mannheimia haemolytica leukotoxin[J]. Vet. Immunol. Immunopathol, 2005,103:187-193.
95. Leite F., Kuckleburg C., Atapattu D., Schultz R., Czuprynski C.J., BHV-1 infection and inflammatory cytokines amplify the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood mononuclear cells in vitro[J]. Vet. Immunol. Immunopathol,2004, 99:193-202.
96. Leite F., Sylte M.J., O'Brien S., Schultz R., Peek S., van Reeth K., Czuprynski C.J., Effect of experimental infection of cattle with bovine herpesvirus-1 (BHV-1) on the ex vivo interaction of bovine leukocytes with Mannheimia (Pasteurella) haemolytica leukotoxin[J].Vet. Immunol. Immunopathol,2002, 84:97-110.
97. Lemaire M., Meyer G., Baranowski E., Schynts F., Wellemans G., Kerkhofs P., Thiry E., Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves [J].J. Clin. Microbiol, 2000,38:4233-4238.
98. Lemaire M., Weynants V., Godfroid J., Schynts F., Meyer G., Letesson J.J., Thiry E., Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response andvirus latency [J]. J. Clin. Microbiol2000,38:1885-1894.
99. Li Y., van Drunen Littel-van den Hurk S., Babiuk L.A., Liang X., Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB[J]. J. Virol,1995, 69:4758-4768.
100. Liang X., Babiuk L.A., Zamb T.J., An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization[J].Virology, 1992,189:629-639 .
101. Liang X., Pyne C., Li Y., Babiuk L.A., Kowalski J., Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry[J].Virology ,1995, 207:429-441 .
102. Liang X.P., Babiuk L.A., van Drunen Littel-van den Hurk S., Fitzpatrick D.R., Zamb T.J., Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV[J]. J. Virol,1991, 65:1124-1132.
103. Ligas M.W., Johnson D.C., A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells[J]. J. Virol,1988,62:1486-1494.
104. Lipinska A.D., Koppers-Lalic D., Rychlowski M., Admiraal P., et.al Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M[J]. J. Virol,2006, 80:5822-5832 .
105. Logan D, Ghazaleh R, Blakemore W, et al. Structure of a major immunogenic site on Foot-and-mouth disease virus [J]. Nature, 1993, 36:566-568
106. Marvin J. Grubman, Barry Baxt. Foot-and-Mouth Disease[J].Clin Microbiol Rev, 2004, 17: 465-93.
107. Mayr GA, Chinsangaram J, Grubman MJ, et.al Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of as a vaccine candidate[J]. Virology, 1999,263:496–506
108. Mayr GA, O’Donnell V, Chinsangaram J, et.al Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs[J].Vaccine, 2001,19:2152–2162
109. Mechor G.D., Rousseaux C.G., Radostits O.M., Babiuk L.A., Petrie L., Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows[J]. Can. J. Vet. Res,1987,51:452-459.
110. Metzler A.E., Matile H., Gassmann U., Engels M., Wyler R., European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies[J].Arch. Virol,1985, 85:57-69 .
111. Meyer G., Hanon E., Georlette D., Pastoret P.P., Thiry E., Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture[J]. J. Gen. Virol,1998,79:1983-1987.
112. Meyer G., Lemaire M., Lyaku J., Pastoret P.P., Thiry E., Establishment of a rabbit model for bovineherpesvirus type 5 neurological acute infection[J].Vet. Microbiol,1996,51:27-40 .
113. Miller J.M., Van der Maaten M.J., Experimentally induced infectious bovine rhinotracheitis virus infection during early pregnancy: effect on the bovine corpus luteum and conceptus[J]. Am. J. Vet. Res,1986, 47:223-228.
114. Miller J.M., Van der Maaten M.J., Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus[J]. Am. J. Vet. Res,1984,45:790-794.
115. Miller J.M., Whetstone C.A., Van der Maaten M.J., Abortifacient property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA[J]. Am. J. Vet. Res,1991,52:458-461.
116. Moraes MP, Mayr GA, Mason PW, et.al Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth diseasevirus (FMDV) strain A24[J]. Vaccine, 2002, 20:1631–1639
117. Muylenkes B, Thiry J, Kirten P et al. Bovine hepervirus 1 infection and infectious bovine rhinotracheitis [J].Vet. Res., 2007, 38:181-209
118. N.J. Knowles, A.R. Samuel. Molecular epidemiology of foot-and-mouth disease virus[J]. Virus Research, 2003, 91: 65-80.
119. Naoaki YOKOYAMA, Ken MAEDA, Takeshi MIKAMI. Recombinant viral vector vaccines for the veterinary use[J]. J.Vet.Med.Sci.1997,59:311-322
120. Narita M., Kimura K., Tanimura N., Arai S., Tsuboi T., Katsuda K., Immunohistochemical characterization of calf pneumonia produced by the combined endobronchial administration of bovine herpesvirus 1 and Pasteurella haemolytica[J]. J. Comp. Pathol,2000, 123:126-134 .
121. Nataraj C., Eidmann S., Hariharan M.J., Sur J.H., Perry G.A., et.al Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules, Viral Immunol[J].1997,10:21-34.
122. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., T et.al Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding[J]. Oligonucleotides ,2006,16:58-67.
123. Okazaki K., Honda E., Kono Y., Expression of bovine herpesvirus 1 glycoprotein gIII by a recombinant baculovirus in insect cells[J]. J. Gen. Virol. (1994) 75:901-904.
124. Okazaki K., Honda E., Kono Y., Heparin-binding domain of bovid herpesvirus 1 glycoprotein gIII[J]. Arch. Virol,1994,134:413-419 .
125. Owen N.V., Chow T.L., Molello J.A., Bovine fetal lesions experimentally produced by infectious bovine rhinotracheitis virus[J].Am. J. Vet. Res,1964,25:1617-1626.
126. Perez Filgueira D.M., Zamorano P.I., Dominguez M.G., et.al Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity[J]. Vaccine ,2003,21:4201-4209 .
127. Qi Hong ,Ping Qian ,Xiang-Min Li et.al A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalentvaccine candidate[J]. Biotechnol Lett ,2007, 29:1677–1683
128. Qian P, Li XM, Jin ML et al.An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine [J].Vaccine, 2004, 22:2129-2136
129. Reddy P.S., Idamakanti N., Chen Y., Whale T., et.al Replication-defective bovine adenovirus type 3 as an expression vector[J]. J. Virol,1999,73:9137-9144.
130. Reynolds A.E., Liang L., Baines J.D., Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34[J]. J. Virol,2004, 78:5564-5575 .
131. Rijsewijk F.A., Kaashoek M.J., Langeveld J.P., Meloen R., Judek J., Bienkowska-Szewczyk K., Maris-Veldhuis M.A., van Oirschot J.T., Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains[J]. J. Gen. Virol,1999,80:1477-1483.
132. Roels S., Charlier G., Letellier C., et.al Natural case of bovine herpesvirus 1 meningoencephalitis in an adult cow[J].Vet. Rec,2000, 146:586-588.
133. Romero CH, Barrett T, Chamberlain RW, et.al Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses[J]. Virology,1994,204(1):425-9.
134. Romero CH, Barrett T, Kitching RP, et.al Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Gen.Virol., 1999, 80: 2839-2848
135. Romero CH, Barrett T, Kitching RP, et.al Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus[J]. Vaccine, 1995,13(1):36-40.
136. Samuel A R, Konules N J. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes) [J]. J General Virol, 2001, 82: 609-621.
137. Sanz-Parra A, Blasco R, Sobrino F, et.al Analysis of the B and T cell response in guinea pigs induced with recombinant vaccine expressing foot-and-mouth disease virus structural proteins[J]. Arch Virol 1998;143(2):389–98.
138. Sanz-Parra A, Vazquez B, Sobrino F, Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing theprecursor poly peptide (P1) of foot-and-mouth disease virus capsid proteins[J]. J Gen Virol 1999;80:671-9.
139. Schmitt J., Becher P., Thiel H.J.et al. Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions[J]. J. Gen.Virol, 1999. 80:2839-2848
140. Schrijver, R. S., Langedijk, J. P. M., Keil, G. M., et al. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV[J]. Vaccine,1997, 15, 1908-1916.
141. Silva AD, Spilki FR, Franco AC, et al. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge[J]. Vaccine,2006,16:3313-20.
142. Smith G.A., Young P.L., Reed K.C., Emergence of a new bovine herpesvirus 1 strain in Australian feedlots[J]. Arch. Virol,1995,140:599-603 .
143. Smith V.W., Coakley W., Maker D., Transmission of a genital isolate of bovine herpesvirus 1 to calves by the respiratory route[J]. Aust. Vet. J,1980,56:302-304.
144. Smith, G.A., Young, P.L., Rodwell, B.J., et.al Development and trial of a bovine herpesvirus 1-thymidine kinase deletion virus as a vaccine[J]. Australian Veterinary Journal, 1994, 71: 65-70.
145. Snowdon, W.A.. Infectious bovine rhinotracheitis and infectious pustular vulvovaginitis in Australian cattle[J]. Australian Veterinary Journal, 1964, 40: 277-288.
146. Solis-Calderon J.J., Segura-Correa V.M., Segura-Correa J.C., Alvarado-Islas A., Seroprevalence of and risk factors for infectious bovine rhinotracheitis in beef cattle herds of Yucatan, Mexico[J].Prev. Vet. Med,2003,57:199-208 .
147. Takashima Y, Xuan X, Kimata I, et al. Recombinant bovine herpesvirus-1 expressing p23 protein of Cryptosporidium parvum induces neutralizing antibodies in rabbits[J]. J Parasitol,2003 89:276-82.
148. Thiry E., Saliki J., Bublot M., Pastoret P.P., Reactivation of infectious bovine rhinotracheitis virus by transport[J].Comp. Immunol. Microbiol. Infect. Dis,1987,10:59-63.
149. Thiry E., Saliki J., Schwers A., Pastoret P.P., Parturition as a stimulus of IBR virus reactivation[J].Vet. Rec,1985,116:599-600.
150. Thiry J., Keuser V., Muylkens B., Meurens F., Gogev S., Vanderplasschen A., Thiry E., Ruminant alphaherpesviruses related to bovine herpesvirus 1[J].Vet. Res,2006,37:169-190.
151. Tikoo S.K., Campos M., Babiuk L.A., Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control, Adv[J]. Virus Res,1995,45:191-223.
152. Valera AR, Pidone CL, Massone AR, et al. A simple method of infecting rabbits with Bovine herpesvirus 1 and 5[J]. J Virol Methods, 2008,150:77-9.
153. Van Drunen Littel-van den Hurk S., Garzon S., van den Hurk J.V., Babiuk L.A., et.al The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity, Virology [J].1995,206:413-425 .
154. Van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., et.al A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle[J]. Vaccine ,1994, 12:1295-1302 .
155. Van Oirschot J.T., Kaashoek M.J., MarisVeldhuis M.A., et.al An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle[J]. J Virol. Methods, 1997, 67:23-34 .
156. Van Oirschot, M.J.Kaashoek, F.A.M.Rijsewijk. Advances in the development and evaluation of bovine herpesvirus 1 vaccines[J]. veterinary microbiology, 1996,53: 43-54.
157. Van Schaik G., Risk and economics of disease introduction to dairy farms, Tijdschr. Diergeneeskd,2001,126:414-418.
158. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Barkema H.W., Benedictus G., Probability of and risk factors for introduction of infectious diseases into Dutch SPF dairy farms: a cohort study[J]. Prev. Vet. Med,2002,54:279-289 .
159. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Benedictus G., Risk factors for introduction of BHV1 into BHV1-free Dutch dairy farms: a case-control study[J]. Vet. Q,2001, 23:71-76.
160. Van Schaik G., Shoukri M., Martin S.W., Schukken Y.H., Nielen M., Hage J.J., Dijkhuizen A.A., Modeling the effect of an outbreak of bovine herpesvirus type 1 on herd-level milk production of Dutch dairy farms[J]. J. Dairy Sci,1999, 82:944-952.
161. Vonk Noordegraaf A., Labrovic A., Frankena K., Pfeiffer D.U., Nielen M., Simulated hazards of loosing infection-free status in a Dutch BHV1 model[J]. Prev. Vet. Med,2004, 62:51-58 .
162. Wang L.S., Menon S., Bolin S.R.et al. A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector[J]. J.Virol. 2003,77:8775-8782.
163. Warren L.M., Babiuk L.A., Campos M., Effects of BHV-1 on PMN adhesion to bovine lung endothelial cells[J]. Vet. Immunol. Immunopathol,1996,55:73-82.
164. Whetstone C.A., Miller J.M., Two different strains of an alphaherpesvirus can establish latency in the same tissue of the host animal: evidence from bovine herpesvirus 1[J].Arch. Virol,1989,107:27-34 .
165. Winkler M.T., Doster A., Jones C., Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle[J].J. Virol,1999,73:8657-8668.
166. Winkler M.T., Doster A., Jones C., Persistence and reactivation of bovine herpesvirus 1 in the tonsils of latently infected calves[J].J. Virol,2000,74:5337-5346 .
167. Wu Q, Brum MC, Caron L, et.al Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J Interferon Cytokine Res[J]. 2003,23(7):359-68.
168. Wu Q, Moraes MP, Grubman MJ. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine[J].Virus Res. 2003,93(2):211-9
169. Yan BF,Chao YJ,Chen Z,et al. Serological survey of bovine herpesvirus type 1 infection in China [J]. Vet Microbiol, 2008, 127:136-41.
170. Zakhartchouk A.N., Pyne C., Mutwiri G.K., P et.al Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1[J].J. Gen. Virol,1999,80:1263-1269.
171. Zheng M, Jin N, Zhang H et al. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus [J].J Virol. Methods, 2006, 136:230-237
172. Zwart D.,The virus of infectious bovine rhinotracheitis in northern Nigeria[J]. Bull Epizoot Dis. Afr.,1996, 14:405-408
2.陈关平. O型口蹄疫与伪狂犬病二价基因工程疫苗的研究.博士学位论文.武汉:华中农业大学,2008.
3.陈焕春,方六荣,何启盖,等.猪伪狂犬病病毒鄂A株的分离鉴定[J].畜牧兽医学报, 1998 2:161-166.
4.陈焕春,周复春,方六荣,等.伪狂犬病病毒鄂A株TK-/gG-/LacZ+突变株的构建[J].病毒学报,2001,17(1):69–74.
5.邓沛霖,贺荣莲,黄峻,等.传染性牛鼻气管炎隐性感染牛的病毒分离[J].中国兽医杂志, 1986, 11: 4-6.
6.邓沛霖,贺荣莲,黄峻,等.广西牛传染性鼻气管炎的血清学调查[J].中国动物检疫, 1988, 1: 11-13.
7.董志强,张志,李晓成,等.口蹄疫病毒VP1基因的克隆及结构蛋白VP1的原核表达[J].中国动物检疫,2007,24(2):23-25
8.段舒怡,姜平,李玉峰,等. O型口蹄疫病毒VP1蛋白单克隆抗体的制备与生物学特性鉴定[J].中国人兽共患病学报,2007,23 (3):240-243
9.费恩阁,李德昌,丁壮. 2004.动物疫病学[M].北京:中国农业出版社. 336-341.
10.谷长维,金宁一,霍晓伟,等.共表达口蹄疫病毒O型P1-2A-IL-18基因和Asia I型P1-2A-3C基因重组鸡痘病毒的构建[J].中国生物制品学杂志,2007,8:658-661
11.郭巍,朱远茂,薛飞等.牛疱疹病毒1型作为活病毒载体的研究进展.中国生物工程杂志, 2005:32-35
13.海岗.表达FMDV vp1基因和山羊γ-干扰素基因的重组山羊痘病毒的构建及其生物学特性研究.博士学位论文.北京:中国农业科学院研究生院,2008.
14.金宁一,张洪勇,尹革芬,等.共表达口蹄疫病毒衣壳蛋白前体P1-2A基因和蛋白酶3C基因重组鸡痘病毒的构建及其免疫原性[J].科学通报,2004,6:576-579
15.孔繁德. 2006.进口奶牛牛传染性鼻气管炎病毒的分离与鉴定[J].中国动物检疫. 23(4): 29-30.
16.李娇,薛飞,朱远茂,等.牛病毒性腹泻病毒E2蛋白的截短表达与鉴定[J].中国预防兽医学报,2008,30(3):200-205
17.李润成,余兴龙,白霞,等. O型口蹄疫病毒代表性抗原VP1基因的人工合成与表达及其免疫原性检测[J].湖南农业大学学报(自然科学版),2008,34(3):334-337
18.刘正飞,陈焕春,周复春,等.伪狂犬病病毒Bartha株TK-/LacZ+突变株的构建及其生物学特性研究[J].畜牧兽医学报,2002,(3):304-307
19.卢曾军,曹轶梅,包惠芳,等.同源重组法制备口蹄疫病毒多基因重组腺病毒[J].中国病毒学,2004(2):30-33
20.吕建亮.口蹄疫病毒泛亚型0/CHINA/99株(全长、缺失和置换)cDNA分子克隆构建和感染性鉴定.硕士学位论文.中国农业科学院研究生院,2008.
21.马鸣潇. FMDV分子背景分析、病毒拯救及多价基因工程疫苗研究.博士学位论文.长春:吉林大学,2007.
22.冉波,邵明玉,张培,等. O型口蹄疫病毒VP1表位重组蛋白疫苗的构建、表达和纯化[J].免疫学杂志,2006,22(3)265-268.
23.王芳.表达FMDV vp1基因的重组山羊痘病毒的构建及其生物学特性研究.博士学位论文.北京:中国农业科学院研究生院,2008.
24.王延涛,李国军,周玉龙,等. 2007.牛传染性鼻气管炎病毒分离鉴定[J].中国兽医杂志. 43(5):30-31.
25.王则兴,李崇华,代瑞良,等.牦牛IBR病毒的分离与鉴定[J].中国兽医科技, 1986, 8: 5-6.
26.薛飞,相文华,沈荣显.山羊试验感染绵羊进行性肺炎病毒的抗体应答反应[J].中国兽医学报,1998,(18):126-128
27.颜邦芬,陈锃,张书环,等.牛传染性鼻气管炎病毒gG蛋白的表达及gG-ELISA的建立[J].生物工程学报,2007,5:806-811.
28.颜邦芬.牛传染性鼻气管炎病毒抗体间接ELISA的建立及其在流行病学研究中的应用.硕士学位论文.武汉:华中农业大学,2007.
29.杨琴,顾江,毛旭虎,等.肠出血性大肠杆菌O157∶H7 TccP基因克隆、表达及其抗原性鉴定[J].中国人兽共患病学报,2007,23 (4):319-322
30.张强.表达口蹄疫病毒P1-2A3C基因的山羊痘病毒弱毒株构建及其复制非必需区筛选博士学位论文.北京:中国农业科学院研究生院,2007.
31.张显升,刘在新,赵启组等.口蹄疫病毒China/99基因组RNA序列测定及比较分析[J].中国科学(C辑),2003,33(5):461-467
32.张永光,吕建亮,王永录,等.口蹄疫O/China/99毒株在不同宿主系传代的3A和VP1基因变异研究[J].病毒学报,2004,20(4)338-346
33.中国农业科学院哈尔滨兽医研究所.动物传染病学,2008,北京:中国农业出版社.
34.周泰冲,叶章名,黎少权,等.从新西兰进口奶牛中分离牛传染性鼻气管炎病毒[J].兽医科技杂志, 1981,1:6-9.
35.朱晶晶,魏玉荣,符子华,等.口蹄疫病毒VP1基因研究进展[J].动物医学进展,2008,29(7):75-78
36.庄娟,曹祥荣,陈波录等. O型口蹄疫病毒VP1 T细胞与B细胞表位基因双拷贝串联表达产物的免疫应答[J].中国预防兽医学报,2005,27(6):494-497
37.祖立闯,朱远茂,王延辉,等.牛传染性鼻气管炎病毒重组gD蛋白间接ELISA方法的建立及应用[J].中国预防兽医学报, 2008,7:537-543.
38.祖立闯.牛传染性鼻气管炎病毒重组gD蛋白间接ELISA的建立与应用.硕士学位论文.哈尔滨:东北农业大学,2008.
39. Abril C., Engels M., Liman A., et al. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient micel[J].J. Viro, 2004,78:3644-3653.
40. Abu-El-Saad AA, Abdel-Moneim AS. Modulation of macrophage functions by sheeppox virusprovides clues to understand interaction of the virus with host immune system[J]. Virol J. 2005, 22:2-22.
41. Ackermann M., Engels M., Pro and contra IBR-eradication [J].Vet.Microbiol,2006 113:293-302 .
42. Ackermann M., Engels M., Pro and contra IBR-eradication[J].Vet Microbiol,2006,113:293–302.
43. AFFA. Discussion paper on bovine herpesvirus 1. Agriculture, Fisheries and Forestry - Australia, Canberra, 2000.
44. Afonso CL, Tulman ER, Lu Z, Zsak L, et.al The genome of swinepox virus[J]. J Virol. 2002 76(2):783-90.
45. Antinone S.E., Shubeita G.T., Coller K.E., et al. The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus[J]. J. Viro, 2006, 80:5494-5498 .
46. Babiuk L.A., van Drunen Littel-van den Hurk S., Tikoo S.K., Immunology of bovine herpesvirus 1 infection[J].Vet. Microbiol,1996,53:31-42 .
47. Bello L.J., Whitbeck J.C., Lawrence W.C. et.al. Bovine herpesvirus 1 as a live virus vector for expression of foreign genes[J]. Virology, 1992,190:666-673.
48. Berhe G, Minet C, Le Goff C, et.al Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections [J] J Virol,2003 77(2):1571-7.
49. Berinstein A, Tami C, Taboga O, et.al Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus[J].Vaccine. 2000, 18(21):2231-8.
50. Bernard Roizman, Frank J.Jenkins et.al Genetic engineering of novel genomes of large DNA viruses[J]. Science, 1985,229:1208-1213.
51. Boelaert F., Speybroeck N., de Kruif A., et al. Risk factors for bovine herpesvirus-1 seropositivity [J].Prev. Vet. Med,2005, 69:285-295 .
52. Bradshaw B.J., Edwards S., Antibody isotype responses to experimental infection with bovine herpesvirus 1 in calves with colostrally derived antibody[J]. Vet. Microbiol,1996, 53:143-151 .
53. Brake, F., Studdert, M.J.. Molecular epidemiology and pathogenesis of ruminant herpesviruses including bovine, buffalo and caprine herpesviruses l and bovine encephalitis herpesvirus[J]. Australian Veterinary Journal, 1985, 62: 331-334.
54. Brown T.T. Jr., Ananaba G., Effect of respiratory infections caused by bovine herpesvirus-1 or parainfluenza-3 virus on bovine alveolar macrophage functions[J]. Am. J. Vet. Res,1988, 49:1447-1451.
55. Campadelli-Fiume G., Cocchi F., Menotti L., Lopez M., The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells l[J]. Rev. Med. Viro, 2000,10:305-319.
56. Campos M., Ohmann H.B., Hutchings D., R et.al Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells[J].Cell. Immunol,1989,120:259-269
57. Campos M., Rossi C.R., Cytotoxicity of bovine lymphocytes after treatment with lymphokines[J].Am. J. Vet. Res,1986, 47:1524-1528.
58. Chow T.L., Molello J.A., Owen N.V., Abortion experimentally induced in cattle by infectious bovine rhinotracheitis virus, J. Am. Vet. Med. Assoc,1964,144:1005-1007.
59. Denis M., Splitter G., Pastoret P.-P., Babiuk L.A., Infectious bovine rhinotracheitis (bovine herpesvirus 1): helper T cells, cytotoxic T cells and NK cells, CRC Press, Boca Raton, 1994.
60. Doel TR. FMD vaccines. Virus Res[J]. 2003;91:81–9
61. D'Offay J.M., Mock R.E., Fulton R.W., Isolation and characterization of encephalitic bovine herpesvirus type 1 isolates from cattle in North America[J]. Am. J. Vet. Res,1993,54:534-539.
62. Dohner K., Wolfstein A., Prank U., Echeverri C., Dujardin D., Vallee R., Sodeik B., Function of dynein and dynactin in herpes simplex virus capsid transport[J]. Mol. Biol. Cell, 2002,13:2795-2809 .
63. Donofrio G, Cavirani S, Vanderplasschen A, et al. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model [J]. Clin Vaccine Immunol,2006,11:1246-54.
64. Donofrio G, Sartori C, Franceschi V,et al. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD[J]. Vaccine,2008,48:6031-42.
65. Du Y, Jiang P, Li Y et al. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor[J].Vaccine,2007,25: 8209-8219
66. Edwards S., Newman R.H., White H., The virulence of British isolates of bovid herpesvirus 1 in relationship to viral genotype[J]. Br. Vet. J,1991,147:216-231.
67. Edwards S., White H., Nixon P., A study of the predominant genotypes of bovid herpesvirus 1 found in the UK[J]. Vet. Microbiol,1990,22:213-223 .
68. Engels M., Steck F., Wyler R., Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction endonuclease analysis[J]. Arch. Virol, 1981,67:169-174 .
69. Garabed RB, Johnson WO, Thurmond MC. Analytical Epidemiology of Genomic Variation among PanAsia Strains of Foot-and-Mouth Disease Virus[J]. Transbound Emerg Dis, 2009,56: 142-56.
70. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G., Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor[J].Science ,1998, 280:1618-1620 .
71. Gerdts V., Beyer J., Lomniczi B., Mettenleiter T.C., Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence[J]. J. Virol,2000,74:817-827 .
72. Gerdts V., Beyer J., Lomniczi B., Mettenleiter T.C., Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence, J.Virol,2000,74:817-827 .
73. Gibbs E.P., Rweyemamu M.M., Bovine herpesviruses. Part I. Bovine herpesvirus 1[J]. Vet. Bull. 1977, 47:317-343.
74. Gogev S., de Fays K., Versali M.F., et.al, Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1[J].Vaccine ,2004,22:1946-1953 .
75. Gogev S., Georgin J.P., Schynts F., et.al Bovine herpesvirus 1 glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 5[J].Vet. Res,2004,35:715-721.
76. Gogev S., Vanderheijden N., Lemaire M., et.al Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD[J]. Vaccine ,2002,20:1451-1465 .
77. Hage J.J., Schukken Y.H., Dijkstra T., Barkema H.W., van Valkengoed P.H., Wentink G.H., Milk production and reproduction during a subclinical bovine herpesvirus 1 infection on a dairy farm[J]. Prev. Vet. Med,1998,34:97-106 .
78. Hage J.J., Vellema P., Schukken Y.H., Barkema H.W., Rijsewijk F.A., van Oirschot J.T., Wentink G.H., Sheep do not have a major role in bovine herpesvirus 1 transmission[J]. Vet. Microbiol, 1997,57:41-54 .
79. Horiuchi M., Yamazaki N., Furuoka H., et.al Restriction endonuclease analysis of bovine herpesvirus type 1 isolates from calves with fatal encephalitis: comparison with vaccine virus[J].J. Vet. Med. Sci,1995, 57:577-580.
80. Ioannou X.P., Griebel P., Hecker R., et.al The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides[J]. J. Virol,2002,76:9002-9010 .
81. Kaashoek M.J., Straver P.H., Van R.E., Quak J., van Oirschot J.T., Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects[J]. Vet. Rec,1996,139:416-421.
82. Kerkhofs P., Renjifo X., Toussaint J.F., Letellier C., Vanopdenbosch E., Wellemans G., Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine[J]. Vet. Rec,2003,152:681-686.
83. King AM, Underwood BO, McCahon D, Newman JW, Brown F Biochemical identification of viruses causing the 1981 outbreaks foot and mouth disease in the UK[J]. Nature 1981;293:479–80.
84. Kit, M., Kit, S., Little, S.P., Di Marchi, R.D., Gale, C.. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine, 1991a, 9: 564-572.
85. Kit, S., Kit, M., DiMarchi, R.D., et.al Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles[J]. Archives of Virology, 1991b, 120: 1-17.
86. Kit, S., Kit, M., McConnell, S.. Intramuscular and intravaginal vaccination of pregnant cows withthymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpes virus 1) [J]. Vaccine, 1986, 4: 55-61.
87. Kit, S., Otsuka, H., Kit, M.. Blocking ELISA for distinguishing infectious bovine rhinotracheitis virus(IBRV)-infected animals from those vaccinated with a gene-deleted marker vaccine[J]. Journal of Virological Methods, 40: 45-56.
88. Kit, S., Qavi, H., Gaines, J.D., et.al Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves[J]. Archives of Virology, 1985, 86: 63-83.
89. Koppers-Lalic D., Reits E.A., Ressing M.E., et.al Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing, Proc. Natl. Acad. Sci. USA [J].2005, 102:5144-5149 .
90. Koppers-Lalic D., Rijsewijk F.A., Verschuren S.B., et.al The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1[J]. J. Gen. Virol,2001, 82:2071-2081.
91. Kuhnle, G., Heinze, A., Schmitt, J., et al. The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1[J]. Journal of Virology, 1998,72,3804-3811.
92. Kweon CH, Kang SW, Choi EJ et al. Bovine herpes virus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate[J]. J. Vet. Med. Sci., 1999, 61(4): 395-401
93. Lehmann D., Sodoyer R., Leterme S., et.al Improvement of serological discrimination between herpesvirus-infected animals and animals vaccinated with marker vaccines[J]. Vet. Microbiol, 2002,86:59-68 .
94. Leite F., Atapattu D., Kuckleburg C., Schultz R., Czuprynski C.J., Incubation of bovine PMNs with conditioned medium from BHV-1 infected peripheral blood mononuclear cells increases their susceptibility to Mannheimia haemolytica leukotoxin[J]. Vet. Immunol. Immunopathol, 2005,103:187-193.
95. Leite F., Kuckleburg C., Atapattu D., Schultz R., Czuprynski C.J., BHV-1 infection and inflammatory cytokines amplify the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood mononuclear cells in vitro[J]. Vet. Immunol. Immunopathol,2004, 99:193-202.
96. Leite F., Sylte M.J., O'Brien S., Schultz R., Peek S., van Reeth K., Czuprynski C.J., Effect of experimental infection of cattle with bovine herpesvirus-1 (BHV-1) on the ex vivo interaction of bovine leukocytes with Mannheimia (Pasteurella) haemolytica leukotoxin[J].Vet. Immunol. Immunopathol,2002, 84:97-110.
97. Lemaire M., Meyer G., Baranowski E., Schynts F., Wellemans G., Kerkhofs P., Thiry E., Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves [J].J. Clin. Microbiol, 2000,38:4233-4238.
98. Lemaire M., Weynants V., Godfroid J., Schynts F., Meyer G., Letesson J.J., Thiry E., Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response andvirus latency [J]. J. Clin. Microbiol2000,38:1885-1894.
99. Li Y., van Drunen Littel-van den Hurk S., Babiuk L.A., Liang X., Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB[J]. J. Virol,1995, 69:4758-4768.
100. Liang X., Babiuk L.A., Zamb T.J., An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization[J].Virology, 1992,189:629-639 .
101. Liang X., Pyne C., Li Y., Babiuk L.A., Kowalski J., Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry[J].Virology ,1995, 207:429-441 .
102. Liang X.P., Babiuk L.A., van Drunen Littel-van den Hurk S., Fitzpatrick D.R., Zamb T.J., Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV[J]. J. Virol,1991, 65:1124-1132.
103. Ligas M.W., Johnson D.C., A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells[J]. J. Virol,1988,62:1486-1494.
104. Lipinska A.D., Koppers-Lalic D., Rychlowski M., Admiraal P., et.al Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M[J]. J. Virol,2006, 80:5822-5832 .
105. Logan D, Ghazaleh R, Blakemore W, et al. Structure of a major immunogenic site on Foot-and-mouth disease virus [J]. Nature, 1993, 36:566-568
106. Marvin J. Grubman, Barry Baxt. Foot-and-Mouth Disease[J].Clin Microbiol Rev, 2004, 17: 465-93.
107. Mayr GA, Chinsangaram J, Grubman MJ, et.al Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of as a vaccine candidate[J]. Virology, 1999,263:496–506
108. Mayr GA, O’Donnell V, Chinsangaram J, et.al Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs[J].Vaccine, 2001,19:2152–2162
109. Mechor G.D., Rousseaux C.G., Radostits O.M., Babiuk L.A., Petrie L., Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows[J]. Can. J. Vet. Res,1987,51:452-459.
110. Metzler A.E., Matile H., Gassmann U., Engels M., Wyler R., European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies[J].Arch. Virol,1985, 85:57-69 .
111. Meyer G., Hanon E., Georlette D., Pastoret P.P., Thiry E., Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture[J]. J. Gen. Virol,1998,79:1983-1987.
112. Meyer G., Lemaire M., Lyaku J., Pastoret P.P., Thiry E., Establishment of a rabbit model for bovineherpesvirus type 5 neurological acute infection[J].Vet. Microbiol,1996,51:27-40 .
113. Miller J.M., Van der Maaten M.J., Experimentally induced infectious bovine rhinotracheitis virus infection during early pregnancy: effect on the bovine corpus luteum and conceptus[J]. Am. J. Vet. Res,1986, 47:223-228.
114. Miller J.M., Van der Maaten M.J., Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus[J]. Am. J. Vet. Res,1984,45:790-794.
115. Miller J.M., Whetstone C.A., Van der Maaten M.J., Abortifacient property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA[J]. Am. J. Vet. Res,1991,52:458-461.
116. Moraes MP, Mayr GA, Mason PW, et.al Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth diseasevirus (FMDV) strain A24[J]. Vaccine, 2002, 20:1631–1639
117. Muylenkes B, Thiry J, Kirten P et al. Bovine hepervirus 1 infection and infectious bovine rhinotracheitis [J].Vet. Res., 2007, 38:181-209
118. N.J. Knowles, A.R. Samuel. Molecular epidemiology of foot-and-mouth disease virus[J]. Virus Research, 2003, 91: 65-80.
119. Naoaki YOKOYAMA, Ken MAEDA, Takeshi MIKAMI. Recombinant viral vector vaccines for the veterinary use[J]. J.Vet.Med.Sci.1997,59:311-322
120. Narita M., Kimura K., Tanimura N., Arai S., Tsuboi T., Katsuda K., Immunohistochemical characterization of calf pneumonia produced by the combined endobronchial administration of bovine herpesvirus 1 and Pasteurella haemolytica[J]. J. Comp. Pathol,2000, 123:126-134 .
121. Nataraj C., Eidmann S., Hariharan M.J., Sur J.H., Perry G.A., et.al Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules, Viral Immunol[J].1997,10:21-34.
122. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., T et.al Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding[J]. Oligonucleotides ,2006,16:58-67.
123. Okazaki K., Honda E., Kono Y., Expression of bovine herpesvirus 1 glycoprotein gIII by a recombinant baculovirus in insect cells[J]. J. Gen. Virol. (1994) 75:901-904.
124. Okazaki K., Honda E., Kono Y., Heparin-binding domain of bovid herpesvirus 1 glycoprotein gIII[J]. Arch. Virol,1994,134:413-419 .
125. Owen N.V., Chow T.L., Molello J.A., Bovine fetal lesions experimentally produced by infectious bovine rhinotracheitis virus[J].Am. J. Vet. Res,1964,25:1617-1626.
126. Perez Filgueira D.M., Zamorano P.I., Dominguez M.G., et.al Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity[J]. Vaccine ,2003,21:4201-4209 .
127. Qi Hong ,Ping Qian ,Xiang-Min Li et.al A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalentvaccine candidate[J]. Biotechnol Lett ,2007, 29:1677–1683
128. Qian P, Li XM, Jin ML et al.An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine [J].Vaccine, 2004, 22:2129-2136
129. Reddy P.S., Idamakanti N., Chen Y., Whale T., et.al Replication-defective bovine adenovirus type 3 as an expression vector[J]. J. Virol,1999,73:9137-9144.
130. Reynolds A.E., Liang L., Baines J.D., Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34[J]. J. Virol,2004, 78:5564-5575 .
131. Rijsewijk F.A., Kaashoek M.J., Langeveld J.P., Meloen R., Judek J., Bienkowska-Szewczyk K., Maris-Veldhuis M.A., van Oirschot J.T., Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains[J]. J. Gen. Virol,1999,80:1477-1483.
132. Roels S., Charlier G., Letellier C., et.al Natural case of bovine herpesvirus 1 meningoencephalitis in an adult cow[J].Vet. Rec,2000, 146:586-588.
133. Romero CH, Barrett T, Chamberlain RW, et.al Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses[J]. Virology,1994,204(1):425-9.
134. Romero CH, Barrett T, Kitching RP, et.al Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Gen.Virol., 1999, 80: 2839-2848
135. Romero CH, Barrett T, Kitching RP, et.al Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus[J]. Vaccine, 1995,13(1):36-40.
136. Samuel A R, Konules N J. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes) [J]. J General Virol, 2001, 82: 609-621.
137. Sanz-Parra A, Blasco R, Sobrino F, et.al Analysis of the B and T cell response in guinea pigs induced with recombinant vaccine expressing foot-and-mouth disease virus structural proteins[J]. Arch Virol 1998;143(2):389–98.
138. Sanz-Parra A, Vazquez B, Sobrino F, Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing theprecursor poly peptide (P1) of foot-and-mouth disease virus capsid proteins[J]. J Gen Virol 1999;80:671-9.
139. Schmitt J., Becher P., Thiel H.J.et al. Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions[J]. J. Gen.Virol, 1999. 80:2839-2848
140. Schrijver, R. S., Langedijk, J. P. M., Keil, G. M., et al. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV[J]. Vaccine,1997, 15, 1908-1916.
141. Silva AD, Spilki FR, Franco AC, et al. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge[J]. Vaccine,2006,16:3313-20.
142. Smith G.A., Young P.L., Reed K.C., Emergence of a new bovine herpesvirus 1 strain in Australian feedlots[J]. Arch. Virol,1995,140:599-603 .
143. Smith V.W., Coakley W., Maker D., Transmission of a genital isolate of bovine herpesvirus 1 to calves by the respiratory route[J]. Aust. Vet. J,1980,56:302-304.
144. Smith, G.A., Young, P.L., Rodwell, B.J., et.al Development and trial of a bovine herpesvirus 1-thymidine kinase deletion virus as a vaccine[J]. Australian Veterinary Journal, 1994, 71: 65-70.
145. Snowdon, W.A.. Infectious bovine rhinotracheitis and infectious pustular vulvovaginitis in Australian cattle[J]. Australian Veterinary Journal, 1964, 40: 277-288.
146. Solis-Calderon J.J., Segura-Correa V.M., Segura-Correa J.C., Alvarado-Islas A., Seroprevalence of and risk factors for infectious bovine rhinotracheitis in beef cattle herds of Yucatan, Mexico[J].Prev. Vet. Med,2003,57:199-208 .
147. Takashima Y, Xuan X, Kimata I, et al. Recombinant bovine herpesvirus-1 expressing p23 protein of Cryptosporidium parvum induces neutralizing antibodies in rabbits[J]. J Parasitol,2003 89:276-82.
148. Thiry E., Saliki J., Bublot M., Pastoret P.P., Reactivation of infectious bovine rhinotracheitis virus by transport[J].Comp. Immunol. Microbiol. Infect. Dis,1987,10:59-63.
149. Thiry E., Saliki J., Schwers A., Pastoret P.P., Parturition as a stimulus of IBR virus reactivation[J].Vet. Rec,1985,116:599-600.
150. Thiry J., Keuser V., Muylkens B., Meurens F., Gogev S., Vanderplasschen A., Thiry E., Ruminant alphaherpesviruses related to bovine herpesvirus 1[J].Vet. Res,2006,37:169-190.
151. Tikoo S.K., Campos M., Babiuk L.A., Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control, Adv[J]. Virus Res,1995,45:191-223.
152. Valera AR, Pidone CL, Massone AR, et al. A simple method of infecting rabbits with Bovine herpesvirus 1 and 5[J]. J Virol Methods, 2008,150:77-9.
153. Van Drunen Littel-van den Hurk S., Garzon S., van den Hurk J.V., Babiuk L.A., et.al The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity, Virology [J].1995,206:413-425 .
154. Van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., et.al A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle[J]. Vaccine ,1994, 12:1295-1302 .
155. Van Oirschot J.T., Kaashoek M.J., MarisVeldhuis M.A., et.al An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle[J]. J Virol. Methods, 1997, 67:23-34 .
156. Van Oirschot, M.J.Kaashoek, F.A.M.Rijsewijk. Advances in the development and evaluation of bovine herpesvirus 1 vaccines[J]. veterinary microbiology, 1996,53: 43-54.
157. Van Schaik G., Risk and economics of disease introduction to dairy farms, Tijdschr. Diergeneeskd,2001,126:414-418.
158. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Barkema H.W., Benedictus G., Probability of and risk factors for introduction of infectious diseases into Dutch SPF dairy farms: a cohort study[J]. Prev. Vet. Med,2002,54:279-289 .
159. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Benedictus G., Risk factors for introduction of BHV1 into BHV1-free Dutch dairy farms: a case-control study[J]. Vet. Q,2001, 23:71-76.
160. Van Schaik G., Shoukri M., Martin S.W., Schukken Y.H., Nielen M., Hage J.J., Dijkhuizen A.A., Modeling the effect of an outbreak of bovine herpesvirus type 1 on herd-level milk production of Dutch dairy farms[J]. J. Dairy Sci,1999, 82:944-952.
161. Vonk Noordegraaf A., Labrovic A., Frankena K., Pfeiffer D.U., Nielen M., Simulated hazards of loosing infection-free status in a Dutch BHV1 model[J]. Prev. Vet. Med,2004, 62:51-58 .
162. Wang L.S., Menon S., Bolin S.R.et al. A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector[J]. J.Virol. 2003,77:8775-8782.
163. Warren L.M., Babiuk L.A., Campos M., Effects of BHV-1 on PMN adhesion to bovine lung endothelial cells[J]. Vet. Immunol. Immunopathol,1996,55:73-82.
164. Whetstone C.A., Miller J.M., Two different strains of an alphaherpesvirus can establish latency in the same tissue of the host animal: evidence from bovine herpesvirus 1[J].Arch. Virol,1989,107:27-34 .
165. Winkler M.T., Doster A., Jones C., Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle[J].J. Virol,1999,73:8657-8668.
166. Winkler M.T., Doster A., Jones C., Persistence and reactivation of bovine herpesvirus 1 in the tonsils of latently infected calves[J].J. Virol,2000,74:5337-5346 .
167. Wu Q, Brum MC, Caron L, et.al Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J Interferon Cytokine Res[J]. 2003,23(7):359-68.
168. Wu Q, Moraes MP, Grubman MJ. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine[J].Virus Res. 2003,93(2):211-9
169. Yan BF,Chao YJ,Chen Z,et al. Serological survey of bovine herpesvirus type 1 infection in China [J]. Vet Microbiol, 2008, 127:136-41.
170. Zakhartchouk A.N., Pyne C., Mutwiri G.K., P et.al Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1[J].J. Gen. Virol,1999,80:1263-1269.
171. Zheng M, Jin N, Zhang H et al. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus [J].J Virol. Methods, 2006, 136:230-237
172. Zwart D.,The virus of infectious bovine rhinotracheitis in northern Nigeria[J]. Bull Epizoot Dis. Afr.,1996, 14:405-408